Pay in 4 interest-free payments of $5.17 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
The most frequent side effects are GI-related, such as nausea and vomiting, and should resolve over time
FOXO4-DRI vs nearby senolytics Option FOXO4-DRI Type D-retro-inverso peptide Human trial stage None (preclinical only) Option Dasatinib + Quercetin (D+Q) Type Small-molecule drug + flavonoid Human trial stage Early human trials (e.g., Alzheimer's) Option Navitoclax Type BCL-2 family inhibitor Human trial stage Later-stage trials (e.g., myelofibrosis) D+Q and navitoclax are further along in humans but can affect healthy cells (e.g., low platelets)
doi: 10.3892/etm.2023.12067
PMID 12185074
US$ 27.29
:max_bytes(150000):strip_icc()/insulin-injection-478185779-594b3cae3df78cae8111498f.jpg)
US$ 25.90
%20(1).png)
US$ 23.18
US$ 29.71
US$ 20.29
US$ 21.08
US$ 29.18
US$ 27.40
